Search results
Results from the WOW.Com Content Network
Grade 1 hypertension. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial, also known as ALLHAT, was a randomized, double-blind, active-controlled study comparing at the same time, four different classes of antihypertensive drugs with the rate of coronary heart disease (CHD) events in ‘high-risk’ people with hypertension. [1]
As the event rate is higher in men than in women, the decrease in events is more easily seen in men than women. [163] In those at risk, but without a history of cardiovascular disease (primary prevention), statins decrease the risk of death and combined fatal and non-fatal cardiovascular disease. [164] The benefit, however, is small. [165]
In 2014, the American Heart Association issued its first guidelines for preventing strokes in women. [1] Just as heart attack systems differ between men and women, men and women also face different stroke risks. For women, the guidelines for preventing strokes focus on factors such as birth control, pregnancy, and depression. [1]
According to research by the Kaiser Family Foundation, about 1 in 8 adults in the U.S. has taken a GLP-1 drug to treat diabetes, promote weight loss or prevent heart attacks or strokes (in those ...
Cardiovascular disease in women is an integral area of research in the ongoing studies of women's health. Cardiovascular disease (CVD) is an umbrella term for a wide range of diseases affecting the heart and blood vessels, including but not limited to, coronary artery disease, stroke, cardiomyopathy, myocardial infarctions, and aortic aneurysms.
For February's American Heart Month, WH breaks down the current research and personal stories of spontaneous coronary artery dissection (SCAD) in women. Thousands Of Women Have Had This Type Of ...
The Original Cohort, founded in 1948, consisted of 5,209 men and women. Requirements for entry were an age between 30 and 62 years at the time of first examination, with no history of heart attack or stroke. Due to lukewarm interest at first, doctors, nurses and healthcare workers volunteered for the study to set an example for patients.
The Caerphilly Heart Disease Study is an epidemiological prospective cohort. The Caerphilly Heart Disease Study, also known as the Caerphilly Prospective Study (CaPS), is an epidemiological prospective cohort, set up in 1979 in a representative population sample drawn from Caerphilly, a typical small town in South Wales, UK.